Maternal obesity and pregnancy outcome
K Sameera Begum1, K Sachchithanantham, S De Somsubhra
1Department of Obstetrics and Gynecology, Melaka Manipal Medical College, Melaka (Malaysa). sameerabgm@yahoo.com
Clinical and Experimental Obstetrics & Gynecology
|April 14, 2011
Summary
Maternal obesity presents significant risks to both mother and fetus during pregnancy, increasing complications like gestational diabetes and preeclampsia. Early preconception interventions are crucial for managing maternal weight and improving outcomes.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Public Health
Background:
- Maternal obesity is a growing global health concern impacting obstetric care.
- Obesity during pregnancy is associated with adverse outcomes for both the mother and the developing fetus.
Purpose of the Study:
- To highlight the challenges and risks associated with maternal obesity in obstetric practice.
- To emphasize the need for informed management and interventions by healthcare professionals.
Main Methods:
- Review of current literature on maternal obesity and its obstetric implications.
- Analysis of risks from preconception through postpartum, including intrapartum care.
- Discussion of long-term health consequences for mother and child.
Main Results:
- Increased maternal risks include gestational diabetes, chronic hypertension, and preeclampsia.
- Fetal risks encompass stillbirth and congenital anomalies.
- Both mother and child face elevated risks of future obesity, heart disease, and diabetes.
Conclusions:
- Maternal obesity necessitates specialized care during pregnancy, delivery, and postpartum.
- Preconception counseling and interventions focused on weight management are essential.
- Obstetrician-gynecologists must be equipped to address this epidemic to mitigate adverse health outcomes.
Related Concept Videos
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...